Home About Cancer News Contact Cancer News
Home About Cancer News Contact Cancer News
Twitter

Archive for August 7th, 2012

« Older Entries

Doctors Talk Ovarian Cancer Signs, Symptoms

By on Tuesday, August 7th, 2012 | No Comments

KCCI-TV’s Molly Nelson reports.

Read More...

"Radiation Vacation" — Beating Prostate Cancer

By on Tuesday, August 7th, 2012 | No Comments

After hearing the words, “You have prostate cancer,” David’s life changed. But little did he know that his life would change for the better… Watch how his “Radiation Vacation” with Proton Treatment at Loma Linda University Medical Center made such a difference in his life. For more information visit www.protons.com

Read More...

Medical Moment: Prostate Cancer

By on Tuesday, August 7th, 2012 | No Comments

Dr. W. Bedford Waters, Urologist, discusses diagnosis and treatment of prostate cancer as well as the recent controversy about prostate cancer screenings: • What is all the confusion about prostate cancer screenings? • What does UT Medical Center recommend for prostate cancer screenings? • How does a man get screened for prostate cancer? • What treatments options are available if a man is diagnoses with prostate cancer? For more information about prostate cancer or urology services available at The University of Tennessee Medical Center, visit our website at www.utmedicalcenter.org or call the Healthcare Coordination office at 865-305-6970

Read More...

Methoxyamine and Fludarabine Phosphate in Treating Patients With Relapsed or Refractory Hematologic Malignancies

By on Tuesday, August 7th, 2012 | No Comments

Conditions :   Adult Nasal Type Extranodal NK/T-cell Lymphoma;   Anaplastic Large Cell Lymphoma;   Angioimmunoblastic T-cell Lymphoma;   Cutaneous B-cell Non-Hodgkin Lymphoma;   Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue;   Hepatosplenic T-cell Lymphoma;   Intraocular Lymphoma;   Nodal Marginal Zone B-cell Lymphoma;   Peripheral T-cell Lymphoma;   Recurrent Adult Burkitt Lymphoma;   Recurrent Adult Diffuse Large Cell Lymphoma;   Recurrent Adult Diffuse Mixed Cell Lymphoma;   Recurrent Adult Diffuse Small Cleaved Cell Lymphoma;   Recurrent Adult Grade III Lymphomatoid Granulomatosis;   Recurrent Adult Hodgkin Lymphoma;   Recurrent Adult Immunoblastic Large Cell Lymphoma;   Recurrent Adult Lymphoblastic Lymphoma;   Recurrent Adult T-cell Leukemia/Lymphoma;   Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma;   Recurrent Grade 1 Follicular Lymphoma;   Recurrent Grade 2 Follicular Lymphoma;   Recurrent Grade 3 Follicular Lymphoma;   Recurrent Mantle Cell Lymphoma;   Recurrent Marginal Zone Lymphoma;   Recurrent Mycosis Fungoides/Sezary Syndrome;   Recurrent Small Lymphocytic Lymphoma;   Refractory Chronic Lymphocytic Leukemia;   Refractory Multiple Myeloma;   Relapsing Chronic Myelogenous Leukemia;   Small Intestine Lymphoma;   Splenic Marginal Zone Lymphoma;   Stage III Chronic Lymphocytic Leukemia;   Testicular Lymphoma;   Waldenström Macroglobulinemia Interventions :   Drug: fludarabine phosphate;   Drug: methoxyamine;   Other: laboratory biomarker analysis;   Other: pharmacological study;   Genetic: western blotting;   Other: mass spectrometry;   Genetic: DNA analysis Sponsors :   Case Comprehensive Cancer Center;   Case Comprehensive Cancer Center;   National Cancer Institute (NCI) Recruiting – verified August 2012

Read More...

Effectiveness of Reduced GCSF Dosing in Patients With a Low to Moderate Risk of Febrile Neutropenia

By on Tuesday, August 7th, 2012 | No Comments

Condition :   Breast Cancer Intervention :   Drug: GCSF administration on days 8 and 12 after chemotherapy Sponsors :   Jules Bordet Institute;   Jules Bordet Institute Recruiting – verified July 2012

Read More...

TAK-700 in Castration Resistant Prostate Cancer

By on Tuesday, August 7th, 2012 | No Comments

Condition :   Prostate Cancer Interventions :   Drug: Orteronel;   Drug: Bicalutamide Sponsors :   European Organization for Research and Treatment of Cancer – EORTC;   European Organization for Research and Treatment of Cancer – EORTC Not yet recruiting – verified August 2012

Read More...

A Randomized, Controlled Study Evaluating the Efficacy and Safety of GS-1101 (CAL-101) in Combination With Ofatumumab for Previously Treated Chronic Lymphocytic Leukemia

By on Tuesday, August 7th, 2012 | No Comments

Condition :   Chronic Lymphocytic Leukemia Interventions :   Drug: Ofatumumab (1000 mg dosing regimen);   Drug: GS-1101;   Drug: Ofatumumab (2000 mg dosing regimen) Sponsors :   Gilead Sciences;   Gilead Sciences Not yet recruiting – verified August 2012

Read More...

A Phase 2, Single-Arm, Open-Label Study Evaluating the Efficacy and Safety of Single Agent GS 1101 (CAL 101) as Therapy for Previously Treated Chronic Lymphocytic Leukemia

By on Tuesday, August 7th, 2012 | No Comments

Condition :   Chronic Lymphocytic Leukemia Intervention :   Drug: GS-1101 Sponsors :   Gilead Sciences;   Gilead Sciences Not yet recruiting – verified August 2012

Read More...

Multiple Ascending Dose

By on Tuesday, August 7th, 2012 | No Comments

Condition :   Hepatocellular Carcinoma Interventions :   Biological: BMS-936558 (Anti-PD-1 antibody);   Biological: BMS-936558 (Anti-PD-1 antibody) Sponsors :   Bristol-Myers Squibb;   Bristol-Myers Squibb Not yet recruiting – verified August 2012

Read More...

Conventional Versus Ultrasound-guided Transbronchial Needle Aspiration for the Diagnosis of Hilar/Mediastinal Lymphadenopathies

By on Tuesday, August 7th, 2012 | No Comments

Conditions :   Mediastinal Lymphadenopathy;   Hilar Lymphadenopathy;   Lymphoma;   Lung Neoplasms;   Sarcoidosis Intervention :   Procedure: EBUS-TBNA Sponsors :   Azienda Ospedaliero, Universitaria Ospedali Riuniti;   Azienda Ospedaliero, Universitaria Ospedali Riuniti Recruiting – verified August 2012

Read More...
« Older Entries